Lemonade (NYSE:LMND) Announces Earnings Results

Lemonade (NYSE:LMNDGet Free Report) posted its quarterly earnings data on Tuesday. The company reported ($0.42) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.61) by $0.19, Zacks reports. Lemonade had a negative net margin of 43.51% and a negative return on equity of 32.85%. The company had revenue of $148.80 million for the quarter, compared to the consensus estimate of $144.78 million. Lemonade updated its FY 2025 guidance to EPS and its Q1 2025 guidance to EPS.

Lemonade Trading Up 20.9 %

Shares of LMND stock traded up $6.59 during trading hours on Thursday, hitting $38.07. 1,996,241 shares of the company were exchanged, compared to its average volume of 2,133,232. The business has a 50 day moving average of $35.27 and a two-hundred day moving average of $29.18. Lemonade has a 52 week low of $14.03 and a 52 week high of $53.85. The company has a market capitalization of $2.72 billion, a PE ratio of -12.46 and a beta of 2.15.

Analysts Set New Price Targets

Several research firms have recently issued reports on LMND. Keefe, Bruyette & Woods downgraded shares of Lemonade from a “market perform” rating to an “underperform” rating and boosted their price objective for the stock from $18.00 to $21.00 in a report on Thursday, November 7th. BMO Capital Markets upped their target price on shares of Lemonade from $13.00 to $15.00 and gave the company an “underperform” rating in a research note on Thursday, November 21st. Morgan Stanley raised shares of Lemonade from an “underweight” rating to an “equal weight” rating and upped their target price for the company from $23.00 to $42.00 in a research note on Wednesday, November 20th. JMP Securities upped their target price on shares of Lemonade from $40.00 to $60.00 and gave the company a “market outperform” rating in a research note on Friday, November 22nd. Finally, Piper Sandler lowered their target price on shares of Lemonade from $44.00 to $34.00 and set a “neutral” rating on the stock in a research note on Wednesday. Three equities research analysts have rated the stock with a sell rating, two have given a hold rating and one has given a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $31.00.

View Our Latest Analysis on LMND

Insider Transactions at Lemonade

In related news, Director Michael A. Eisenberg sold 12,000 shares of the firm’s stock in a transaction on Friday, December 13th. The shares were sold at an average price of $40.15, for a total value of $481,800.00. Following the completion of the transaction, the director now owns 94,670 shares of the company’s stock, valued at approximately $3,801,000.50. This trade represents a 11.25 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider John Sheldon Peters sold 1,790 shares of the firm’s stock in a transaction on Tuesday, December 3rd. The shares were sold at an average price of $45.50, for a total transaction of $81,445.00. Following the completion of the transaction, the insider now directly owns 88,493 shares of the company’s stock, valued at approximately $4,026,431.50. This trade represents a 1.98 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 769,657 shares of company stock valued at $33,868,724 over the last quarter. Corporate insiders own 12.50% of the company’s stock.

Lemonade Company Profile

(Get Free Report)

Lemonade, Inc provides various insurance products through various channels in the United States, Europe, and the United Kingdom. Its insurance products include stolen or damaged property, and personal liability that protects its customers if they are responsible for an accident or damage to another person or their property.

Recommended Stories

Earnings History for Lemonade (NYSE:LMND)

Receive News & Ratings for Lemonade Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lemonade and related companies with MarketBeat.com's FREE daily email newsletter.